The Ticker Graveyard

Lyra Therapeutics, Inc. terminated its lease for approximately 23,704 square feet, incurring a $2.1 million payment as part of the exit strategy.

Zenvia Inc. was delisted from the Nasdaq Capital Market on March 9, 2026, following its Form 25 filing for voluntary withdrawal.

Aris Mining Corp voluntarily delisted from NYSE American LLC, with Form 25 filed on February 20, 2026, certifying compliance with SEC regulations.

Strata Skin Sciences, Inc. was delisted from Nasdaq on February 19, 2026, after failing to meet minimum stockholders' equity requirements.

Anebulo Pharmaceuticals, Inc. filed for delisting after significant financial setbacks reported in its February 12, 2026, filing.

Venus Concept Inc. (VERO) was delisted from NASDAQ in 2026 after failing to overcome financial instability and operational inefficiencies despite numerous restructuring efforts.

Vasta Platform Ltd. voluntarily delisted from NASDAQ on January 20, 2026, citing compliance with SEC regulations.

Telefónica S.A. was delisted from the New York Stock Exchange on August 2, 2021, following voluntary withdrawal from listing and registration requirements under Section 12(b) of the Securities Exchange Act of 1934.

Cybin Inc. was delisted from the NYSE American LLC on January 2, 2026, following a notification of removal from listing due to compliance issues.

Glen Burnie Bancorp voluntarily delisted its common stock from Nasdaq and deregistered with the SEC as of December 12, 2025, marking the end of its public reporting obligations.

Old Market Capital Corporation announced its voluntary delisting from NASDAQ and transitioned to OTC trading effective January 2, 2026, due to cost and regulatory considerations.

Tile Shop Holdings, Inc. executed a 1-for-3,000 reverse stock split and subsequently announced delisting following significant stockholder cash-outs on December 26, 2025.

Carisma Therapeutics Inc. (CARM) faced a decline in investor confidence leading to its eventual delisting after a failed strategic license agreement and subsequent financial instability.

Clearside Biomedical, Inc. filed for Chapter 11 bankruptcy on November 25, 2025, following sustained financial difficulties.

Gold.com, Inc. was delisted from the NYSE following operational challenges and governance changes, culminating in diminished investor confidence as noted in a Form 8-K filed on 2026-03-16.

DiamondRock Hospitality Company (DRH-PA) was delisted following operational downturns and financial instability highlighted in its recent SEC filings.

Carver Bancorp Inc. voluntarily delisted its common stock from NASDAQ on November 18, 2025, to transition to the OTCQX Market amid ongoing financial challenges.

TAITRON COMPONENTS INC (TAIT) voluntarily delisted from NASDAQ on December 4, 2025, due to a decline in shareholder base below 300.

Lazydays Holdings, Inc. (GORV) ceased operations and was delisted from Nasdaq on November 28, 2025, following a bankruptcy-driven asset sale and liquidation plan.

Opthea Ltd was delisted from Nasdaq on November 10, 2025, due to non-compliance with audit committee requirements.

On November 10, 2025, Genfit S.A. was delisted from Nasdaq following its voluntary withdrawal of American Depository Shares, impacted by setbacks in clinical trials.

Light & Wonder, Inc. was delisted in 2026 following a decline in financial performance and compliance issues with exchange listing standards.

Adaptimmune Therapeutics PLC voluntarily delisted from Nasdaq in October 2025 due to compliance issues with listing standards.

HarborOne Bancorp, Inc. was delisted following a merger with Eastern Bankshares, Inc., effective August 20, 2025, upon approval of shareholders on July 2, 2025.

CompoSecure, Inc. (CMPO) faced delisting following a failed shareholder vote on a major acquisition.

Beachbody Company, Inc. was delisted from Nasdaq due to financial underperformance and failure to meet listing standards, as reported on March 10, 2026.

COSCIENS Biopharma Inc. voluntarily delisted from Nasdaq on August 26, 2025, following significant operational challenges.

Associated Capital Group, Inc. voluntarily delisted from the NYSE on August 15, 2025, due to the burdens of regulatory compliance outweighing its benefits.

Sunrise Communications AG voluntarily withdrew its American Depositary Shares from listing on The Nasdaq Stock Market on August 6, 2025.

Crown Electrokinetics Corp. terminated its accounting engagement with Frank, Rimerman + Co. LLP, citing amicable reasons without disagreements, as per the 8-K filing on January 12, 2026.

Third Harmonic Bio, Inc. voluntarily dissolved and delisted from Nasdaq following stockholder approval on June 5, 2025, with a formal Certificate of Dissolution filed on July 31, 2025.

HOOKIPA Pharma Inc. liquidated after selling key assets to Gilead Sciences and dissolving the company following approval from stockholders, marking the end of its clinical-stage pursuits.

S&W Seed Company faced financial distress leading to a UCC asset sale valued at approximately $7 million on August 1, 2025.

Playa Hotels & Resorts N.V. delisted after being acquired by Hyatt Hotels Corporation at $13.50 per share on April 17, 2025.

Brooge Energy Ltd was formally delisted from the Nasdaq Stock Market on December 19, 2024, after submitting a Form 25 notification of removal from listing.

CSW Industrials, Inc. was delisted from the New York Stock Exchange following declining financial performance and operational challenges, culminating in a Form 8-K filing on January 29, 2026.

Chrome Holding Co. (MEHCQ), a SPAC aiming to merge with 23andMe, failed to complete its Business Combination and was subsequently delisted.

QVC Group, Inc. ceased operations as an independent entity following a reorganization with Liberty Interactive, transforming into GCI Liberty, Inc. on February 2, 2018.

TIC Solutions, Inc. was delisted from the New York Stock Exchange in March 2026 following critical operational and financial challenges post its acquisition of NV5 Global, Inc.

SYLA Technologies Co., Ltd. was delisted from the Nasdaq on May 19, 2025, following a voluntary withdrawal of its securities registration according to SEC regulations.

Therapeutic Solutions International, Inc. voluntarily delisted its securities from the OTC Markets on April 22, 2025, due to strategic considerations.

Vincerx Pharma, Inc. was delisted from Nasdaq following post-merger operational challenges leading to significant declines in its stock performance.

First Financial Northwest, Inc. voluntarily announced plans to dissolve after a significant asset sale to Global Federal Credit Union, as detailed in its June 2024 proxy statement.

Syra Health Corp was delisted from the OTCQB following operational challenges and financial underperformance disclosed in its 2026 filings.

Enzo Biochem Inc. was delisted after announcing a merger, proposed to be completed on August 19, 2025, at a price of $0.70 per share.